Endologix (ELGX) Misses Q4 EPS by 6c

Endologix (NASDAQ: ELGX) reported Q4 EPS of ($0.22), $0.06 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $39.2 million versus the consensus estimate of $39.97 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• S&P 500 eyes record as retail slump, Iran risk set up pivotal week
• Empire Petroleum posts $11.1M revenue in Q2 2026, narrows net loss